КОМОРБИДНАЯ ПАТОЛОГИЯ У ПАЦИЕНТОВ С МНОГОСОСУДИСТЫМ ПОРАЖЕНИЕМ КОРОНАРНОГО РУСЛА

Purpose: to study the features of comorbid pathology in patients with multivessel lesions of coronary arteries who underwent stenting of the coronary arteries and received only optimal medication. Methods: A retrospective analysis of the case histories of 144 patients with lesion of the LCA trunk in combination with the lesion of two or more coronary arteries was carried out according to the coronary angiography, which was in inpatient treatment at RSNPMC in 2014. All patients were divided into 2 groups: with the stenting of the symptom-related coronary artery and, if necessary, the other coronary arteries, and received only optimal medication (OMT). In addition, each group was divided into 2 subgroups according to the age principle: older and younger than 65 years. The fact of the presence of concomitant pathology was judged from the analysis of medical records and the results of inpatient examination of patients. Results: there was a significant difference in the occurrence of such nosologies as: hypertension (GB) (69.6 % versus 92.3 %, p = 0,01), COPD (2.5 % vs. 10.8 %, p = 0, 04), CHF IIB (0 % vs. 4.6 %, p = 0,05), encephalopathy (8.9 % vs. 33.8 %, p = 0,001) in the group of stent patients compared with patients who received OMT. In the comparative analysis within the groups, by age subgroups, the expected difference in the stages of CHF was observed: the prevalence of CHF II A stage in the older age group of patients undergoing PCI (80 % vs. 55.6 %, p = 0,03), while CHF II B stage, was observed only in the older age group of patients who received OMT (11.5 % vs. 0, p = 0,03). Conclusion: Patients with coronary artery disease with multivessel lesions who received optimal medication, are characterized by more severe comorbidity. An increase in the patient’s age is associated with an increase in cardiovascular comorbidity in the absence of a significant increase in other concomitant pathologies.